SEC EDGAR Filing Information

Form 10-K -- Annual report [Section 13 and 15(d), not S-K Item 405]

Period of Report: 2008-12-31
Filing Date Changed: 2009-03-12
Documents: 7
SEC Accession No.
0001193125-09-052156
Filing date: 2009-03-12
Accepted: 2009-03-12 16:01:36

Table of submitted documents:

Seq Type Document Size Description
1 10-K d10k.htm 3194282 FORM 10-K FOR THE FISCAL YEAR ENDED DECEMBER 31, 2008
2 EX-10.4 dex104.htm 52892 FORM OF EXECUTIVE EMPLOYMENT AGREEMENT
3 EX-21 dex21.htm 9738 SUBSIDIARIES OF THE REGISTRANT
4 EX-31.1 dex311.htm 10402 CERTIFICATION OF CHIEF EXECUTIVE OFFICER
5 EX-31.2 dex312.htm 10618 CERTIFICATION OF CHIEF FINANCIAL OFFICER
6 EX-32.1 dex321.htm 3680 CERTIFICATION OF CHIEF EXECUTIVE OFFICER
7 EX-32.2 dex322.htm 3733 CERTIFICATION OF CHIEF FINANCIAL OFFICER
0001193125-09-052156.txt 3287409 Complete submission text file

Filer Information:

US ONCOLOGY INC (Filer) (0000943061)
IRS No.: 841213501 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26190 | Film No.: 09675738
SIC: 8093 Services-Specialty Outpatient Facilities, NEC

  Assistant Director 1
Business Address
16825 NORTHCHASE DR
STE 1300
HOUSTON TX 77060
2818732674
 Mailing Address

US Oncology Holdings, Inc. (Filer) (0001333191)
IRS No.: 200873619 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-126922 | Film No.: 09675737
SIC: 8060 Services-Hospitals

  Assistant Director 1
Business Address
16825 NORTHCHASE DRIVE, SUITE 1300
HOUSTON TX 77060
(832) 601-8766
 Mailing Address
16825 NORTHCHASE DRIVE, SUITE 1300
HOUSTON TX 77060